Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1989 Mar;65(761):129–135. doi: 10.1136/pgmj.65.761.129

Halothane and liver damage.

D Rosenak 1, A Halevy 1, R Orda 1
PMCID: PMC2429259  PMID: 2682584

Full text

PDF
129

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen P. J., Downing J. W. A prospective study of hepatocellular function after repeated exposures to halothane or enflurane in women undergoing radium therapy for cervical cancer. Br J Anaesth. 1977 Oct;49(10):1035–1039. doi: 10.1093/bja/49.10.1035. [DOI] [PubMed] [Google Scholar]
  2. BRODY G. L., SWEET R. B. Halothane anesthesia as a possible cause of massive hepatic necrosis. Anesthesiology. 1963 Jan-Feb;24:29–37. doi: 10.1097/00000542-196301000-00005. [DOI] [PubMed] [Google Scholar]
  3. BUNKER J. P., BLUMENFELD C. M. Liver necrosis after halothane anesthesia. Cause or coincidence? N Engl J Med. 1963 Mar 7;268:531–534. doi: 10.1056/NEJM196303072681005. [DOI] [PubMed] [Google Scholar]
  4. BURNAP T. K., GALLA S. J., VANDAM L. D. Anesthetic, circulatory and respiratory effects of fluothane. Anesthesiology. 1958 May-Jun;19(3):307–320. doi: 10.1097/00000542-195805000-00001. [DOI] [PubMed] [Google Scholar]
  5. Bentley J. B., Vaughan R. W., Gandolfi A. J., Cork R. C. Halothane biotransformation in obese and nonobese patients. Anesthesiology. 1982 Aug;57(2):94–97. doi: 10.1097/00000542-198208000-00005. [DOI] [PubMed] [Google Scholar]
  6. Blogg C. E. Halothane and the liver: the problem revisited and made obsolete. Br Med J (Clin Res Ed) 1986 Jun 28;292(6537):1691–1692. doi: 10.1136/bmj.292.6537.1691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown B. R., Jr Pharmacogenetics and the halothane hepatitis mystery. Anesthesiology. 1981 Aug;55(2):93–94. doi: 10.1097/00000542-198108000-00001. [DOI] [PubMed] [Google Scholar]
  8. Böttiger L. E., Dalén E., Hallén B. Halothane-induced liver damage: an analysis of the material reported to the Swedish Adverse Drug Reaction Committee, 1966-1973. Acta Anaesthesiol Scand. 1976;20(1):40–46. doi: 10.1111/j.1399-6576.1976.tb05007.x. [DOI] [PubMed] [Google Scholar]
  9. Canalese J., Wyke R. J., Vergani D., Eddleston A. L., Williams R. Circulating immune complexes in patients with fulminant hepatic failure. Gut. 1981 Oct;22(10):845–848. doi: 10.1136/gut.22.10.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cascorbi H. F., Gorsky B. H., Redford J. E. Sex differences in anaesthetic toxicity: fluroxene and trifluoroethanol in mice. Br J Anaesth. 1976 May;48(5):399–402. doi: 10.1093/bja/48.5.399. [DOI] [PubMed] [Google Scholar]
  11. Cohen E. N., Trudell J. R., Edmunds H. N., Watson E. Urinary metabolites of halothane in man. Anesthesiology. 1975 Oct;43(4):392–401. doi: 10.1097/00000542-197510000-00004. [DOI] [PubMed] [Google Scholar]
  12. DYKES M. H., WALZER S. G., SLATER E. M., GIBSON J. M., ELLIS D. S. ACUTE PARENCHYMATOUS HEPATIC DISEASE FOLLOWING GENERAL ANESTHESIA: CLINICAL APPRAISAL OF HEPATOTOXICITY FOLLOWING ADMINISTRATION OF HALOTHANE. JAMA. 1965 Aug 2;193:339–344. doi: 10.1001/jama.1965.03090050015005. [DOI] [PubMed] [Google Scholar]
  13. Dundee J. W. Problems of multiple inhalation anaesthetics. Br J Anaesth. 1981;53 (Suppl 1):63S–67S. [PubMed] [Google Scholar]
  14. Dykes M. H. Unexplained postoperative fever. Its value as a sign of halothane sensitization. JAMA. 1971 Apr 26;216(4):641–644. doi: 10.1001/jama.216.4.641. [DOI] [PubMed] [Google Scholar]
  15. Fee J. P., Black G. W., Dundee J. W., McIlroy P. D., Johnston H. M., Johnston S. B., Black I. H., McNeill H. G., Neill D. W., Doggart J. R. A prospective study of liver enzyme and other changes following repeat administration of halothane and enflurane. Br J Anaesth. 1979 Dec;51(12):1133–1141. doi: 10.1093/bja/51.12.1133. [DOI] [PubMed] [Google Scholar]
  16. Hughes M., Powell L. W. Recurrent hepatitis in patients receiving multiple halothane anesthetics for radium treatment of carcinoma of the cervix uteri. Gastroenterology. 1970 Jun;58(6):790–797. [PubMed] [Google Scholar]
  17. Inman W. H., Mushin W. W. Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of Medicines. Br Med J. 1978 Nov 25;2(6150):1455–1456. doi: 10.1136/bmj.2.6150.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Inman W. H., Mushin W. W. Jaundice after repeated exposure to halothane: an analysis of Reports to the Committee on Safety of Medicines. Br Med J. 1974 Jan 5;1(5896):5–10. doi: 10.1136/bmj.1.5896.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. JOHNSTONE M. The human cardiovascular response to fluothane anaesthesia. Br J Anaesth. 1956 Sep;28(9):392–410. doi: 10.1093/bja/28.9.392. [DOI] [PubMed] [Google Scholar]
  20. KRANTZ J. C., Jr, PARK C. S., TRUITT E. B., Jr, LING A. S. Anesthesia. LVII. A further study of the anesthetic properties of 1,1,1,trifluoro-2,2-bromochlorethane (fluothane). Anesthesiology. 1958 Jan-Feb;19(1):38–44. [PubMed] [Google Scholar]
  21. Klatskin G., Kimberg D. V. Recurrent hepatitis attributable to halothane sensitization in an anesthetist. N Engl J Med. 1969 Mar 6;280(10):515–522. doi: 10.1056/NEJM196903062801001. [DOI] [PubMed] [Google Scholar]
  22. Klion F. M., Schaffner F., Popper H. Hepatitis after exposure to halothane. Ann Intern Med. 1969 Sep;71(3):467–477. doi: 10.7326/0003-4819-71-3-467. [DOI] [PubMed] [Google Scholar]
  23. LINDENBAUM J., LEIFER E. Hepatic necrosis associated with halothane anesthesia. N Engl J Med. 1963 Mar 7;268:525–530. doi: 10.1056/NEJM196303072681004. [DOI] [PubMed] [Google Scholar]
  24. Lewis J. H., Zimmerman H. J., Ishak K. G., Mullick F. G. Enflurane hepatotoxicity. A clinicopathologic study of 24 cases. Ann Intern Med. 1983 Jun;98(6):984–992. doi: 10.7326/0003-4819-98-6-984. [DOI] [PubMed] [Google Scholar]
  25. Lorhan P. H. Halothane and liver damage. N Engl J Med. 1969 Mar 6;280(10):562–562. doi: 10.1056/NEJM196903062801016. [DOI] [PubMed] [Google Scholar]
  26. MUSHIN W. W., ROSEN M., BOWEN D. J., CAMPBELL H. HALOTHANE AND LIVER DYSFUNCTION: A RETROSPECTIVE STUDY. Br Med J. 1964 Aug 8;2(5405):329–341. doi: 10.1136/bmj.2.5405.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McLain G. E., Sipes I. G., Brown B. R., Jr An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia. Anesthesiology. 1979 Oct;51(4):321–326. doi: 10.1097/00000542-197910000-00008. [DOI] [PubMed] [Google Scholar]
  28. Miller D. J., Dwyer J., Klatskin G. Halothane hepatitis: benign resolution of a severe lesion. Ann Intern Med. 1978 Aug;89(2):212–215. doi: 10.7326/0003-4819-89-2-212. [DOI] [PubMed] [Google Scholar]
  29. Moult P. J., Sherlock S. Halothane-related hepatitis. A clinical study of twenty-six cases. Q J Med. 1975 Jan;44(173):99–114. [PubMed] [Google Scholar]
  30. Mushin W. W., Rosen M., Jones E. V. Post-halothane jaundice in relation to previous administration of halothane. Br Med J. 1971 Jul 3;3(5765):18–22. doi: 10.1136/bmj.3.5765.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Neuberger J., Williams R. Halothane anaesthesia and liver damage. Br Med J (Clin Res Ed) 1984 Oct 27;289(6452):1136–1139. doi: 10.1136/bmj.289.6452.1136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nunez-Gornes J. F., Marx J. J., Jr, Motszko C. Leukocyte migration inhibition in halothane-induced hepatitis. Clin Immunol Immunopathol. 1979 Sep;14(1):30–34. doi: 10.1016/0090-1229(79)90122-3. [DOI] [PubMed] [Google Scholar]
  33. Otsuka S., Yamamoto M., Kasuya S., Ohtomo H., Yamamoto Y., Yoshida T. O., Akaza T. HLA antigens in patients with unexplained hepatitis following halothane anesthesia. Acta Anaesthesiol Scand. 1985 Jul;29(5):497–501. doi: 10.1111/j.1399-6576.1985.tb02242.x. [DOI] [PubMed] [Google Scholar]
  34. Paronetto F., Popper H. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med. 1970 Aug 6;283(6):277–280. doi: 10.1056/NEJM197008062830602. [DOI] [PubMed] [Google Scholar]
  35. Peters R. L., Edmondson H. A., Reynolds T. B., Meister J. C., Curpey T. J. Hepatic necrosis associated with halothane anesthesia. Am J Med. 1969 Nov;47(5):748–764. doi: 10.1016/0002-9343(69)90168-5. [DOI] [PubMed] [Google Scholar]
  36. Powell-Jackson P., Greenway B., Williams R. Adverse effects of exploratory laparotomy in patients with unsuspected liver disease. Br J Surg. 1982 Aug;69(8):449–451. doi: 10.1002/bjs.1800690805. [DOI] [PubMed] [Google Scholar]
  37. Price C. D., Gibbs A. R., Williams W. J. Halothane macrophage migration inhibtiion factor test in halothane-associated hepatitis. J Clin Pathol. 1977 Apr;30(4):312–316. doi: 10.1136/jcp.30.4.312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. RAVENTOS J. The action of fluothane; a new volatile anaesthetic. Br J Pharmacol Chemother. 1956 Dec;11(4):394–410. doi: 10.1111/j.1476-5381.1956.tb00007.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rehder K., Forbes J., Alter H., Hessler O., Stier A. Halothane biotransformation in man: a quantitative study. Anesthesiology. 1967 Jul-Aug;28(4):711–715. doi: 10.1097/00000542-196707000-00018. [DOI] [PubMed] [Google Scholar]
  40. Rodriguez M., Paronetto F., Schaffner F., Popper H. Antimitochondrial antibodies in jaundice following drug administration. JAMA. 1969 Apr 7;208(1):148–150. [PubMed] [Google Scholar]
  41. Ross W. T., Jr, Daggy B. P., Cardell R. R., Jr Hepatic necrosis caused by halothane and hypoxia in phenobarbital-treated rats. Anesthesiology. 1979 Oct;51(4):327–333. doi: 10.1097/00000542-197910000-00009. [DOI] [PubMed] [Google Scholar]
  42. SLATER E. M., GIBSON J. M., DYKES M. H., WALZER S. G. POSTOPERATIVE HEPATIC NECROSIS. ITS INCIDENCE AND DIAGNOSTIC VALUE IN ASSOCIATION WITH THE ADMINISTRATION OF HALOTHANE. N Engl J Med. 1964 May 7;270:983–987. doi: 10.1056/NEJM196405072701904. [DOI] [PubMed] [Google Scholar]
  43. STEPHEN C. R., MARGOLIS G., FABIAN L. W., BOURGEOIS-GAVARDIN M. Laboratory observations with fluothane. Anesthesiology. 1958 Nov-Dec;19(6):770–781. doi: 10.1097/00000542-195811000-00009. [DOI] [PubMed] [Google Scholar]
  44. SUCKLING C. W. Some chemical and physical factors in the development of fluothane. Br J Anaesth. 1957 Oct;29(10):466–472. doi: 10.1093/bja/29.10.466. [DOI] [PubMed] [Google Scholar]
  45. Schatzki P. F., Kay S., McGavic J. D. Ultrastructural pathology of a case of halothane hepatitis. Am J Dig Dis. 1973 Oct;18(10):905–911. doi: 10.1007/BF01073343. [DOI] [PubMed] [Google Scholar]
  46. Schlippert W., Anuras S. Recurrent hepatitis following halothane exposures. Am J Med. 1978 Jul;65(1):25–30. doi: 10.1016/0002-9343(78)90688-5. [DOI] [PubMed] [Google Scholar]
  47. Sharpstone P., Medley D. R., Williams R. Halothane hepatitis--a preventable disease? Br Med J. 1971 Feb 20;1(5746):448–450. doi: 10.1136/bmj.1.5746.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Simpson B. R., Strunin L., Walton B. The halothane dilemma: a case for the defence. Br Med J. 1971 Oct 9;4(5779):96–100. doi: 10.1136/bmj.4.5779.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sipes I. G., Gandolfi A. J., Pohl L. R., Krishna G., Brown B. R., Jr Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane. J Pharmacol Exp Ther. 1980 Sep;214(3):716–720. [PubMed] [Google Scholar]
  50. Smith M. G., Williams R., Walker G., Rizzetto M., Doniach D. Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J. 1974 Apr 13;2(5910):80–84. doi: 10.1136/bmj.2.5910.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Stephen C. R. Halothane and liver damage. N Engl J Med. 1969 Mar 6;280(10):561–562. doi: 10.1056/NEJM196903062801013. [DOI] [PubMed] [Google Scholar]
  52. Stock J. G., Strunin L. Unexplained hepatitis following halothane. Anesthesiology. 1985 Oct;63(4):424–439. doi: 10.1097/00000542-198510000-00014. [DOI] [PubMed] [Google Scholar]
  53. Strunin L., Harrison L. J., Davies J. M. Etiology of halothane hepatotoxicity. Anesthesiology. 1983 Apr;58(4):391–391. doi: 10.1097/00000542-198304000-00025. [DOI] [PubMed] [Google Scholar]
  54. Strunin L. Liver dysfunction after repeated anaesthesia. Br J Anaesth. 1979 Dec;51(12):1097–1099. doi: 10.1093/bja/51.12.1097. [DOI] [PubMed] [Google Scholar]
  55. TORNETTA F. J., TAMAKI H. T. Halothane jaundice andhepatotoxicity. JAMA. 1963 May 25;184:658–660. doi: 10.1001/jama.1963.73700210021020b. [DOI] [PubMed] [Google Scholar]
  56. Thomas F. B. Chronic aggressive hepatitis induced by halothane. Ann Intern Med. 1974 Oct;81(4):487–489. doi: 10.7326/0003-4819-81-4-487. [DOI] [PubMed] [Google Scholar]
  57. Trey C., Lipworth L., Chalmers T. C., Davidson C. S., Gottlieb L. S., Popper H., Saunders S. J. Fulminant hepatic failure. Presumable contribution to halothane. N Engl J Med. 1968 Oct 10;279(15):798–801. doi: 10.1056/NEJM196810102791504. [DOI] [PubMed] [Google Scholar]
  58. Trowell J., Peto R., Smith A. C. Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium. Lancet. 1975 Apr 12;1(7911):821–824. [PubMed] [Google Scholar]
  59. Uzunalimoglu B., Yardley J. H., Boitnott J. K. The liver in mild halothane hepatitis. Light and electron microscopic findings with special reference to the mononuclear cell infiltrate. Am J Pathol. 1970 Dec;61(3):457–478. [PMC free article] [PubMed] [Google Scholar]
  60. Van Dyke R. A., Gandolf A. J. Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents. Drug Metab Dispos. 1976 Jan-Feb;4(1):40–44. [PubMed] [Google Scholar]
  61. Van Dyke R. A., Wood C. L. In vitro studies on irreversible binding of halothane metabolite to microsomes. Drug Metab Dispos. 1975 Jan-Feb;3(1):51–57. [PubMed] [Google Scholar]
  62. Vergani D., Tsantoulas D., Eddleston A. L., Davis M., Williams R. Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia. Lancet. 1978 Oct 14;2(8094):801–803. doi: 10.1016/s0140-6736(78)92585-0. [DOI] [PubMed] [Google Scholar]
  63. Walton B., Simpson B. R., Strunin L., Doniach D., Perrin J., Appleyard A. J. Unexplained hepatitis following halothane. Br Med J. 1976 May 15;1(6019):1171–1176. doi: 10.1136/bmj.1.6019.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Widger L. A., Gandolfi A. J., Van Dyke R. A. Hypoxia and halothane metabolism in vivo: release of inorganic fluoride and halothane metabolite binding to cellular constituents. Anesthesiology. 1976 Mar;44(3):197–201. doi: 10.1097/00000542-197603000-00004. [DOI] [PubMed] [Google Scholar]
  65. Williams B. D., White N., Amlot P. L., Slaney J., Toseland P. A. Circulating immune complexes after repeated halothane anaesthesia. Br Med J. 1977 Jul 16;2(6080):159–162. doi: 10.1136/bmj.2.6080.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Wills E. J., Walton B. A morphologic study of unexplained hepatitis following halothane anesthesia. Am J Pathol. 1978 Apr;91(1):11–32. [PMC free article] [PubMed] [Google Scholar]
  67. Wright R., Eade O. E., Chisholm M., Hawksley M., Lloyd B., Moles T. M., Edwards J. C., GArdner M. J. Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet. 1975 Apr 12;1(7911):817–820. doi: 10.1016/s0140-6736(75)93000-7. [DOI] [PubMed] [Google Scholar]
  68. Young S. R., Stoelting R. K., Peterson C., Madura J. A. Anesthetic biotransformation and renal function in obese patients during and after methoxyflurane or halothane anesthesia. Anesthesiology. 1975 Apr;42(4):451–457. doi: 10.1097/00000542-197504000-00015. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES